Genprex, Inc. (NASDAQ:GNPX) traded at $3.14 at last check on Friday, Nov 20, making an upward move of 0.64% on its previous day’s price.
Looking at the stock we see that its previous close was $3.12 and the beta (5Y monthly) reads 0 with the day’s price range being $3.0300 – 3.1800. The company has a 12-month trailing PE ratio of 0. In terms of its 52-week price range, GNPX has a high of $7.03 and a low of $0.23. The company’s stock has gained about -6.55% over that past 30 days.
On the other hand, looking at the outlook for the GNPX stock, short term indicators assign the stock an average of 100% Sell, while medium term indicators assign it an average of Hold. Long term indicators on average place the stock in the category of 50% Sell.
Let’s briefly compare Genprex, (GNPX) stock to its peers. We find that today’s price change of +0.64% and +939.05% over the past 12 months for GNPX betters that of Bristol-Myers Squibb Company (BMY), which has seen its stock price fall -0.77% in the latest trading session and is +8.37% over the last one year. Another of its peers Amgen Inc (AMGN) has dropped -0.67% today, but is -2.04% down over the past year, while Gilead Sciences Inc (GILD) is also up 0.64% yet its price remains in the green at 939.05% over the same period. Bristol-Myers has a P/E ratio of 0 compared to Genprex,’s 0 and Amgen’s 17.99. In contrast to these companies, both the S&P 500 Index and the Dow Jones Industrial are today at -0.68% and -0.75%, respectively, in early deals.
Coming back to Genprex, Inc. (NASDAQ:GNPX), we note that the average 3-month trading volume was 767.14 Million, while that of the preceding 10-day period stands at 401.49 Million. Current shares outstanding are 39.62 Million.
According to data from Thomson Reuters, insiders hold 19.07% of the company’s shares while institutions hold 17.58%. The data shows that short shares as of October 29, 2020, stood at 3.03 Million at a short ratio of 4.46. This represents a 7.78% Short interest in Shares outstanding on October 29, 2020. Shares short dropped in October from the previous month at 3.15 Million. Investors should be excited about this stock as its upside potential is great, with today’s price pushing the stock +881.25% up in year-to-date price movement.